Entry Date:
October 15, 2015

Novel Approaches to Antibody-Drug Conjugates


Antibody-Drug Conjugates (ADCs) for cancer therapy are synthesized by attaching cytotoxic small molecule drugs to monoclonal antibodies, using chemical linkers. The team is developing novel linkers to attach the drugs to antibodies. These linkers should allow for a much more effective cancer therapy.